Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredShares IssuedShares OutstandingShares Outstanding
Ratios

Fulcrum Therapeutics (FULC) Receivables - Other (2020 - 2025)

Fulcrum Therapeutics (FULC) has disclosed Receivables - Other for 6 consecutive years, with $979000.0 as the latest value for Q1 2025.

  • Quarterly Receivables - Other changed N/A to $979000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $979000.0 through Mar 2025, changed N/A year-over-year, with the annual reading at $2.1 million for FY2024, 290.32% up from the prior year.
  • Receivables - Other for Q1 2025 was $979000.0 at Fulcrum Therapeutics, down from $2.1 million in the prior quarter.
  • The five-year high for Receivables - Other was $3.7 million in Q3 2024, with the low at $99000.0 in Q1 2023.
  • Average Receivables - Other over 5 years is $1.2 million, with a median of $700000.0 recorded in 2021.
  • The sharpest move saw Receivables - Other crashed 90.84% in 2022, then surged 530.34% in 2024.
  • Over 5 years, Receivables - Other stood at $2.5 million in 2021, then plummeted by 90.84% to $229000.0 in 2022, then surged by 134.5% to $537000.0 in 2023, then soared by 290.32% to $2.1 million in 2024, then plummeted by 53.29% to $979000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $979000.0, $2.1 million, and $3.7 million for Q1 2025, Q4 2024, and Q3 2024 respectively.